When psoriasis is extensive, disabling, or attacking the joints, treating it from the outside stops being enough. These are the drugs that work from the inside: powerful, well-evidenced, and requiring proper monitoring.
Systemic treatment is considered when disease is extensive, when it has failed adequate topical and phototherapy trials, when it is disabling out of proportion to its area, palms and soles are the classic example, or when there is psoriatic arthritis, because joints do not respond to anything applied to skin.
That last point deserves emphasis. Joint damage in psoriatic arthritis is irreversible, and the window in which treatment prevents it is early. A patient with joint symptoms is not someone to try another cream on.
The trade is real and it is discussed openly: these drugs suppress immune function and require monitoring. For the right patient the balance is strongly favourable. For someone with mild, limited disease it is not, and the honest answer is to stay on the lower rungs.
Dr. (Lt Col) Khagendra Varada
Reg. No. 10461, Hyderabad State Medical Council
Full background →“I have been going pillar to post to get my son cured of his white spot on his left side of lip and chin. It appeared 8 years back. I was told it’s special type of nerve vitiligo which has no cure. After reporting to him he told us that it is SEGMENTAL VITILIGO and unlikely and difficult to be cleared by medications alone. He suggested for surgical melanocyte transplant… I was amazed after around one month that he started rapidly getting pigmentation. I wholeheartedly suggest please do not waste time like I did.”
“Dr. Varada is an incredibly patient, knowledgeable and wonderful doctor. He sorted out an issue that I had been dealing with for years in one appointment and there’s been no looking back since!”
Treatment is a sequence, not a menu. Creams, then light, then tablets, then the targeted injections — each rung asks more of you in monitoring than the one below it, and none of them is skipped for convenience.
The wedge under the steps is the monitoring each rung asks of you — it thickens the whole way up. Nobody starts at the top, and nobody should be left at the bottom for years if it is not working. Where you enter depends on how much skin is involved and what it is doing to your life.
Illustration, not a photograph.
| Drug | Suits | Requires |
|---|---|---|
| Methotrexate | Extensive disease; also treats psoriatic arthritis | Regular blood counts and liver monitoring; no alcohol excess; not in pregnancy |
| Ciclosporin | Rapid control of a severe flare; short-term use | Blood pressure and kidney monitoring; time-limited courses |
| Acitretin | Palmoplantar and pustular disease | Lipid and liver monitoring; strict pregnancy avoidance for years after |
| Apremilast | Moderate disease where monitoring is difficult | No routine blood monitoring; nausea and weight loss common early |
Choice depends on your other conditions as much as on the psoriasis: liver, kidneys, blood pressure, alcohol use and pregnancy plans all narrow the list before anything else is considered.
Conventional systemics damp the immune system broadly. A biologic is an antibody built to catch one specific inflammatory signal before it reaches the cell it was sent to — which is why it acts so precisely, and why the drugs are named after the signal they block.
Blocking one signal is also why screening matters: the same signal has a job in fighting infection. That is what the tuberculosis and hepatitis tests before starting are for.
Illustration, not a photograph.
Biologics are injected antibodies that block a single specific inflammatory messenger driving psoriasis, rather than suppressing immune function broadly.
Latent tuberculosis and hepatitis B and C are screened for before any biologic is started. In India, TB screening is not a formality.
The main barrier in India is cost, and biosimilars have changed but not removed it. Adalimumab, etanercept, infliximab and ustekinumab have Indian biosimilars; secukinumab and ixekizumab are sold as the originator; the newest agents are import-only. Figures are on the cost page and discussed frankly before starting.
Every systemic drug here has a monitoring schedule, and the schedule exists because the problems it catches are silent until they are not. Methotrexate can affect blood counts and the liver without any symptom at all until damage is done.
So treatment is not started unless the monitoring is realistic for you, which for patients outside Hyderabad means agreeing where blood tests will be done locally and how results will reach the clinic.
Arrange a systemic-therapy reviewBloods, and screening where a biologic is planned. Nothing starts before the baseline is in hand.
Out-of-state patients have bloods done locally and reviewed by video. It works, provided it is agreed in advance.
When disease is extensive, has failed adequate topical and phototherapy treatment, or when psoriatic arthritis is present. Methotrexate treats both skin and joints, which phototherapy does not.
It requires respect rather than fear. Regular blood monitoring catches the problems that matter, alcohol must be limited, and it is absolutely avoided in pregnancy. Within those boundaries it has decades of safe use in psoriasis.
Yes. Adalimumab, etanercept, infliximab and ustekinumab are sold as Indian biosimilars; secukinumab and ixekizumab as the originator products; guselkumab, risankizumab and bimekizumab only by named-patient import. Cost remains the main barrier for most patients, it is set out on the cost page, and it is discussed openly before starting rather than after.
Biologics can reactivate latent tuberculosis. Given TB prevalence in India, screening before starting is essential and is not optional.
Sometimes, with a planned reduction. Psoriasis usually returns after stopping, so the decision balances how long remission has held against the burden of continuing. It is never stopped abruptly.
Several are absolutely contraindicated: methotrexate and acitretin in particular, with acitretin requiring pregnancy avoidance for years after stopping. Tell the clinic about pregnancy plans before starting anything, not after.
The clinical statements on this page follow the guidance and evidence below. They are independent sources. None of them is connected to this clinic, and none of them sells the treatments described here.
Not a treatment plan sold on the spot. Message the clinic and bring your history.